Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
Taj Logo
especially Products
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom

Indicated for Short-term Treatment of Ulcer in Adults

HOME >> PRODUCTS >> Prilosid

Taj  ALL Products View Products According to Category


It is a gastric proton pump inhibitor. Omeprazole is a substituted benzimidazole derivative acting on the final step of acid production & therefore controls intragastric acidity irrespective of stimulus. It markedly inhibits basal and stimulated gastric acid secretion. Thus it is antisecretory drug which is very effective for rapidly healing peptic ulcers & erosive oesophagitis & for reducing gastric acid hyper-secretion in patients with Zollinger-Ellison syndrome.

The drug acts by relaxing blood vessels so that blood passes through them more easily. This further helps to lower blood pressure.

Gastric ulcer: 20 mg once daily for 8 weeks in sever cases increase to 0 40 mg once daily
Duodenal ulcer: 20 mg once daily for 4 weeks.
Zollinger Ellison Syndrome: 60 mg once daily.
Maintenance therapy: 20 0120 mg adjusted to response.

Contra- Indications: Hypersensitivity, neonates

Side Effects
The drug has certain side effects, that can affect individuals in different ways. The following are some of the side effects, that are often associated with the drug:

* Skin rash
* Nausea
* Headache
* Constipation
* Flatulence

Duodenal Ulcer (adults)

Prilosid is indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy.
Gastric Ulcer (adults)

Prilosid Capsules (Omeprazole)

Prilosid is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer in adults.

Concomitant Gastric Malignancy

Symptomatic response to therapy with omeprazole does not preclude the presence of gastric malignancy.
Atrophic Gastritis

Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with omeprazole.


Prilosid Delayed-Release Capsules are contraindicated in patients with known hypersensitivity to any component of the formulation.

Clarithromycin is contraindicated in patients with a known hypersensitivity to any macrolide antibiotic.

Concomitant administration of clarithromycin with cisapride, pimozide, or terfenadine is contraindicated. There have been post-marketing reports of drug interactions when clarithromycin and/or erythromycin are co-administered with cisapride, pimozide, or terfenadine resulting in cardiac arrhythmias (QT prolongation, ventricular tachycardia, ventricular fibrillation, and torsades de pointes) most likely due to inhibition of hepatic metabolism of these drugs by erythromycin and clarithromycin. Fatalities have been reported. (Please refer to full prescribing information for clarithromycin before prescribing.)

Capsules              Strip of 10 Capsules

Note :
This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).




Indicated for Short-term Treatment of Ulcer in Adults

    Prilosid ® Taj Products
Product Gallery
PDF Download
Doc Download
MSDS Download
COA Download
 Prescription Products (Rx)

Larger View


Larger View




 Print page   Send by mail

  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market

  gastric proton pump inhibitor

























About Taj


Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors


Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement